{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifvvzqybmftmvcaw3c2krcpqfblc2ttrj2bzpjapdxhrgsgcwyjte",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mkn6vrzgey32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicw72c7k2aygaobpy7pqxce7yygdobfmvfvoomdfn7zo4p2osf474"
    },
    "mimeType": "image/webp",
    "size": 82082
  },
  "path": "/releases/2026/04/260428045556.htm",
  "publishedAt": "2026-04-29T01:28:38.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles.",
  "title": "A forgotten drug is giving new hope to kids with a rare disease"
}